Continuous MDA Hydrogenation for Low Trans/Trans PACM

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing processes for producing methylenebis(cyclohexylamine) face challenges in achieving defined proportions of isomers, particularly low trans/trans content, due to thermodynamic equilibrium favoring higher trans/trans ratios, leading to inefficiencies in product turnover and energy consumption.

Innovation Solution

A continuous catalytic hydrogenation process using a plant with a conditioning unit, reactor unit, and separation unit, incorporating fixed-bed reactors, heat exchangers, and separation stages, allows for precise control of isomer ratios through independent temperature management and energy coupling, enabling the production of methylenebis(cyclohexylamine) with a low trans/trans isomer content.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional hydrogenation processes are used, then thermodynamic equilibrium is achieved, but the trans/trans isomer content becomes too high (up to 51.2%)

Engineering Contradiction:
Improveisomer ratio controlVSAvoidtrans/trans isomer content
Core Design Contradiction:
Manufacturing precisionVSStability of the object's composition

Solution Approach 1:

The patent applies dynamics by making the reaction conditions variable rather than static. The process uses staged hydrogenation where reaction temperature, pressure, and catalyst type are changed between stages. The first stage uses mild conditions (lower temperature, different catalyst) to limit trans/isomer formation, then the second stage adjusts conditions to achieve final conversion. This dynamic approach allows the system to avoid thermodynamic equilibrium that would otherwise favor high trans/trans content.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The hydrogenation process is divided into multiple stages with different reaction conditions. Stage 1 uses specific catalysts and conditions to achieve partial conversion with controlled isomer distribution. Stage 2 then completes the hydrogenation under different conditions. This segmentation allows each stage to be optimized independently, preventing the single-stage thermodynamic equilibrium problem while achieving the desired low trans/trans isomer content in the final product.

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If prolonged tempering is used to shift equilibrium towards trans/trans isomers, then isomer composition changes, but production time increases

Engineering Contradiction:
Improveisomer compositionVSAvoidproduction time
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The process performs preliminary action by controlling isomer formation during the hydrogenation reaction itself rather than relying on post-reaction tempering. The staged approach with specific catalysts and conditions in the first stage pre-determines the isomer distribution before the reaction completes, eliminating the need for prolonged tempering to shift equilibrium. This achieves the desired isomer composition as part of the main reaction process, not as a separate time-consuming step.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If high trans/trans content product is produced, then thermodynamic equilibrium is satisfied, but product applicability is limited

Engineering Contradiction:
Improvethermodynamic equilibriumVSAvoidproduct application range
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by systematically varying reaction parameters (temperature, pressure, catalyst type, solvent) between stages to control isomer formation. The first stage uses parameters optimized for selective hydrogenation with limited isomerization, while the second stage uses different parameters for complete conversion. This parameter control allows production of products with specific isomer profiles matched to different applications, expanding adaptability beyond what single equilibrium conditions can provide.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves a precise control of isomer ratios, reducing energy consumption and improving product turnover by maintaining a low trans/trans fraction in the product, enhancing the efficiency and quality of methylenebis(cyclohexylamine) production.

Implementation Method 1

continuous catalytic hydrogenation of MDA

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

hydrogenation of MDA is strongly exothermic

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Implementation Method 3

The hydrogenation of MDA is strongly exothermic. WO 2010/069484 A1, for example, gives a reaction enthalpy of -1600 kJ/mol

Methodology Applied
Scientific EffectExothermic Reaction: Exothermic Reaction

Implementation Method 4

a reactor unit (102) comprising at least one fixed-bed reactor as a main reactor (200) with an immobile catalyst packing, in particular a ruthenium-doped or -doped catalyst packing

Methodology Applied
Scientific EffectHeat Exchanger: Heat Exchanger

Implementation Method 5

a separation unit (106) comprising at least a first separation stage (106A) for a separation of the solvent and a second separation stage (106B) for a separation of at least one reactant and/or at least one by-product from the product

Methodology Applied
Scientific EffectDistillation: Distillation

Data Source

PatentEP4685131A1Process for the continuous catalytic hydrogenation of mda
Publication Date: 2026.01.28 EVONIK OPERATIONS GMBH
  • EP4685131A1 patent drawingFigure 1
  • EP4685131A1 patent drawingFigure 2
  • EP4685131A1 patent drawingFigure 3

AI summary

Plant for the hydrogenation of methylenedianiline (MDA; reactant 1) with a hydrogen source (reactant 2), in particular a gaseous hydrogen source, preferably hydrogen (H2), comprising a conditioning unit for the reactants, a reactor unit for the synthesis of PACM, and a separation unit, wherein: - the conditioning unit comprises at least one partial length of the (supply) lines for reactants 1, reactant 2, and at least one solvent, at least one heat exchanger in at least one (supply) line, and at least one mixer for mixing the reactants and/or at least one reactant with at least one solvent; - the reactor unit comprises at least one fixed-bed reactor as the main reactor with an immobile catalyst packing, wherein the at leastA (first) main reactor comprises a first flow path for the mixture via the immobile catalyst packing and a further, separate, closed flow path for a heat exchange medium outside the catalyst packing, wherein a heat exchanger is integrated into the media circulation; the separation unit comprises at least a first separation stage for (essentially) separating the solvent and a second separation stage for (essentially) separating the reactant and by-products from the product PACM, wherein the separation unit in the first separation stage comprises at least a pressure control unit and a separation vessel with a condensation unit for the solvent, wherein a (return) line for the solvent leads from the at least one condensation unit of the first separation stage to the conditioning unit. The invention further comprises an associated method.